Cargando…
A Systematic Review of the Role of Purinergic Signalling Pathway in the Treatment of COVID-19
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global health concern. Three years since its origin, despite the approval of vaccines and specific treatments against this new coronavirus, there are still high rate...
Autores principales: | Korb, Vitoria Guero, Schultz, Iago Carvalho, Beckenkamp, Liziane Raquel, Wink, Márcia Rosângela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178215/ https://www.ncbi.nlm.nih.gov/pubmed/37175571 http://dx.doi.org/10.3390/ijms24097865 |
Ejemplares similares
-
Purinergic signaling elements are correlated with coagulation players in peripheral blood and leukocyte samples from COVID-19 patients
por: Schultz, Iago C., et al.
Publicado: (2022) -
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis
por: Schultz, Iago Carvalho, et al.
Publicado: (2021) -
MSC-Exosomes Carrying miRNA – Could they Enhance Tocilizumab Activity in Neuropathology of COVID-19?
por: Schultz, Iago C., et al.
Publicado: (2022) -
Purinergic signaling pathway in severe
COVID-19
por: Arruvito, Lourdes, et al.
Publicado: (2023) -
Dissecting the Purinergic Signaling Puzzle
por: Pérez-Sen, Raquel, et al.
Publicado: (2021)